Scientists Turn Toxic Mold Compounds Into Powerful Cancer-Fighting Drugs

PHILADELPHIA — Scientists have discovered how to turn molecules made by everyday toxic mold into highly effective cancer-fighting drugs, potent enough to rival some of the best treatments for leukemia currently available. This surprise breakthrough came when researchers figured out how to rework natural chemicals from common household fungi so they could enter cancer cells and shut them down.

The team from the University of Pennsylvania, Rice University, and other institutions may have solved one of the thorniest problems in cancer drug design: how to get compounds inside tumor cells where they can actually do damage. Published in Nature Chemical Biology, the findings offer a new approach to developing precision cancer drugs using natural ingredients that might be found growing in your basement.

From Household Mold to Cancer Medicine

The research centers around a group of natural chemicals called asperigimycins, which are made by Aspergillus molds, organisms that often live in damp areas like bathrooms, kitchens, and soil. In nature, these molds use asperigimycins to defend themselves against competing microbes. Scientists saw potential in these complex molecules, but at first, they had no effect on cancer.

That changed when the team made a tiny adjustment: they attached a small, fat-like tail to one version of the compound. This small chemical tweak turned a weak and ineffective molecule into a powerful cancer-killing drug, effective at incredibly low doses.

The new version, called 2-L6, was especially effective against leukemia in lab tests, killing cancer cells while leaving other cells, like liver and cervical cancer cells, mostly unharmed. In head-to-head comparisons, 2-L6 performed just as well as two chemotherapy drugs already used to treat leukemia: cytarabine and daunorubicin.

Cracking the Code on Cell Entry

One of the biggest challenges in designing cancer drugs is getting them inside the tumor cells. Many drugs work well in theory, but they can’t break through the cell’s outer wall. That’s what makes this discovery so important.

To find out how 2-L6 gets into cancer cells, the researchers used a tool called CRISPR, which allowed them to systematically turn off genes one at a time and see which ones made a difference. They found that a specific protein, SLC46A3, acts like a door that helps the drug enter cells.

When this “door” was missing, cancer cells were 30 times more resistant to the drug. That means cancers with more of this protein may be easier to treat with 2-L6, while those with less might not respond as well. Identifying this protein could help doctors predict which patients would benefit most from the treatment.

Once inside, 2-L6 works in two ways: it prevents cancer cells from dividing by interfering with their internal scaffolding (called tubulin), and it disrupts systems the cells use to recycle damaged proteins, which are systems that cancer often depends on to stay alive.

Turning Mold Genes Into a Drug Factory

To make these new drugs, scientists had to understand how mold naturally builds asperigimycins. They uncovered a set of six mold genes that work together like an assembly line, piecing together the molecule’s unusual ring-shaped structure.

The most powerful version of the compound, 2-L6, was made by taking this natural structure and adding a simple 11-carbon fat-like chain at one end. This made it easier for the compound to pass through cell membranes and reach its target.

In lab tests, 2-L6 worked against several different types of leukemia cells, including lines known as Jurkat, Mino, and Molm-14. Researchers measured how much drug was needed to kill half the cancer cells, and 2-L6 consistently performed well at very low concentrations.

This kind of precision engineering opens the door to new cancer treatments that are not only effective, but also more selective, killing cancer cells while sparing healthy ones. With thousands of mold species producing unique chemicals, the researchers say there’s a whole untapped world of potential drugs waiting to be discovered.

---